BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9678269)

  • 1. Residents and pharmaceutical representatives.
    Lexchin J
    Can Fam Physician; 1998 Jul; 44():1448. PubMed ID: 9678269
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical marketing: implications for medical residency training.
    Anastasio GD; Little JM
    Pharmacotherapy; 1996; 16(1):103-7. PubMed ID: 8700788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teaching information mastery: evaluating information provided by pharmaceutical representatives.
    Shaughnessy AF; Slawson DC; Bennett JH
    Fam Med; 1995 Oct; 27(9):581-5. PubMed ID: 8829983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians, pharmaceutical representatives, and patients: who really benefits?
    Westfall JM
    J Fam Pract; 2000 Sep; 49(9):817-9. PubMed ID: 11032206
    [No Abstract]   [Full Text] [Related]  

  • 7. There is no such thing as a free lunch. Developing policies on pharmaceutical industry support.
    Newton W; Goldstein A; Frey J
    J Fam Pract; 1992 Jan; 34(1):32-4. PubMed ID: 1728651
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing the door on pharma? A national survey of family medicine residencies regarding industry interactions.
    Fugh-Berman A; Brown SR; Trippett R; Bell AM; Clark P; Fleg A; Siwek J
    Acad Med; 2011 May; 86(5):649-54. PubMed ID: 21436662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential partners: attitudes of family practice residents toward collaboration with social workers in their future practices.
    Frangos AS; Chase D
    Soc Work Health Care; 1976; 2(1):65-76. PubMed ID: 1019812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.
    Agrawal S; Saluja I; Kaczorowski J
    Acad Med; 2004 Nov; 79(11):1046-50. PubMed ID: 15504769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug promotion in a family medicine training center: 21 years later.
    Madlon-Kay DJ
    Fam Med; 2009 Jun; 41(6):386-7. PubMed ID: 19492179
    [No Abstract]   [Full Text] [Related]  

  • 13. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pharmaceutical companies.
    Messmer JJ
    J Fam Pract; 2000 Dec; 49(12):1154; author reply 1155. PubMed ID: 11132069
    [No Abstract]   [Full Text] [Related]  

  • 15. What residents don't know about physician-pharmaceutical industry interactions.
    Watkins RS; Kimberly J
    Acad Med; 2004 May; 79(5):432-7. PubMed ID: 15107282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of cardiology residents toward interactions with the pharmaceutical industry.
    Moubarak G; Martins RP; Zuily S; Mechulan A; Hariri S; Guiot A
    Int J Cardiol; 2011 Feb; 146(3):461-2. PubMed ID: 21122930
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical sales reps: value beyond samples.
    Flewell MN
    Adv Nurse Pract; 2006 Jul; 14(7):18. PubMed ID: 16977890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.